Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

story of the week

Published in Respiratory Medicine

Journal Scan / Research · March 23, 2022

Efficacy of Gefapixant in the Treatment of Chronic Cough

The Lancet

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Peter Gibson FRACP, FThorSoc, DMed (Research)

Emmett Kistler MD

Dennis Thomas M.Pharm, PhD

The Lancet

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

Lancet 2022 Mar 05;399(10328)909-923, LP McGarvey, SS Birring, AH Morice, PV Dicpinigaitis, ID Pavord, J Schelfhout, AM Nguyen, Q Li, A Tzontcheva, B Iskold, SA Green, C Rosa, DR Muccino, JA Smith

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Efficacy of Gefapixant in the Treatment of Chronic Cough

Additional Info

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

Further Reading

Effect of Enteral vs Parenteral Phosphate Replacement on Biochemistry, Waste, and Environmental Impact and Healthcare Cost Among Patients With Critical Illness With Mild to Moderate Hypophosphatemia

Efficacy of Nirmatrelvir in the Treatment of Vaccinated or Unvaccinated Adult Outpatients With COVID-19

Pathophysiology, Clinical Impact, and Management of Atrial Arrhythmias Among Patients With Pulmonary Hypertension

Challenges Associated With the Initiation and Management of ECMO Support

Association Between Emergency-Authorized Nonconventional Ventilator Use and Mortality Among Patients With COVID-19–Associated ARDS

Comparison Between Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting TB

Flow Cytometry as an Alternative to Microscopy for the Differentiation of Bronchoalveolar Lavage Fluid Leukocytes

Racial Differences in Respiratory Impairment, Pneumoconiosis, and Federal Compensation Among Indigenous Coal Miners in Western US

Delirium and Incident Dementia Among Patients Admitted to Hospitals in New South Wales, Australia

Effectiveness of an Artificial Intelligence–Enabled Intervention for Detecting Clinical Deterioration

Inappropriate Diagnosis of Pneumonia Among Hospitalized Adults

Recently Updated